Načítá se...

Secukinumab for ankylosing spondylitis and psoriatic arthritis

The treatment of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) positively changed since the introduction of anti-TNFα drugs. These treatments were shown to reduce the symptoms and signs of the diseases and improve the quality of life. However, a variable percentage of patients do not res...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Clin Risk Manag
Hlavní autoři: Lubrano, Ennio, Perrotta, Fabio Massimo
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085310/
https://ncbi.nlm.nih.gov/pubmed/27799780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S100091
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!